Columbia CureGN network for primary glomerular kidney diseases
The Columbia PCC for CureGN: the Cure Glomerulonephropathy network
This network follows children and adults with primary glomerular kidney diseases and collects health data and samples to improve care and understanding.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11381246 on NIH RePORTER |
What this research studies
If I join, researchers will collect my medical records, blood and urine samples, and patient-reported information over time to track how my kidney condition changes. The project enrolls people with minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), IgA nephropathy (IgAN), and membranous nephropathy (MN) from many clinical sites. The effort includes nearly 2,800 participants and is run by a consortium of academic centers, a data coordinating center, and patient advocacy groups. The collected biospecimens and data are used for clinical, mechanistic, and translational studies that aim to guide future treatments and care.
Who could benefit from this research
Good fit: Children and adults diagnosed with MCD, FSGS, IgAN, or MN are the ideal candidates for participation.
Not a fit: People without these specific glomerular diseases, or those already on long-term dialysis or living with a kidney transplant, are unlikely to gain direct benefit from this network.
Why it matters
Potential benefit: If successful, this work could lead to better ways to diagnose, monitor, and personalize treatment for people with these glomerular diseases.
How similar studies have performed: Earlier registries and cohort studies have produced important insights, and CureGN expands on that success with a larger, more detailed, multi-site design.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Bomback, Andrew Stephen — Columbia University Health Sciences
- Study coordinator: Bomback, Andrew Stephen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.